Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ANIK
ANIK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ANIK News
Xilio Therapeutics Appoints New Board Member
3d ago
Globenewswire
Xilio Therapeutics Appoints Cheryl R. Blanchard to Board
3d ago
Newsfilter
Telix Pharmaceuticals Appoints New Non-Executive Directors
Apr 08 2026
Globenewswire
Telix Pharmaceuticals Appoints New Non-Executive Directors
Apr 08 2026
Newsfilter
TELIX ENHANCES BOARD WITH NEW DIRECTOR APPOINTMENTS
Apr 08 2026
moomoo
Anika Grants Restricted Stock Units to New Employee
Apr 03 2026
Newsfilter
Healthcare Stocks Show Overbought Warning Signals
Mar 04 2026
Benzinga
Anika Therapeutics Q4 2025 Earnings Call Insights
Feb 26 2026
seekingalpha
Anika Therapeutics Releases Fiscal 2026 Guidance with Q4 Earnings Beat
Feb 26 2026
seekingalpha
Anika Therapeutics to Announce Q4 Earnings on February 26
Feb 25 2026
seekingalpha
Anika Therapeutics Faces Investor Lawsuit Over Securities Violations
Jan 26 2026
Globenewswire
Anika Therapeutics Shares Plunge 27% After Clinical Trial Fails to Meet Primary Endpoints
Jan 24 2026
Businesswire
Anika Therapeutics Shares Plunge 27.42% After Clinical Trial Results Fail to Meet Primary Endpoints
Dec 30 2025
Businesswire
Anika Therapeutics Faces Investigation After 27.42% Stock Drop Following Clinical Trial Results
Dec 30 2025
Newsfilter
Anika Therapeutics Faces Investigation After Hyalofast Trial Misses Key Endpoints
Dec 06 2025
Globenewswire
Anika Therapeutics Faces Investigation After 27.42% Stock Drop Due to Trial Results
Dec 06 2025
Newsfilter
Show More News
